Dasatinib hydrochloride
CAS: 854001-07-3
Rif. 3D-EJB00107
| 25mg | 136,00 € | ||
| 50mg | 167,00 € | ||
| 100mg | 236,00 € | ||
| 250mg | 353,00 € | ||
| 500mg | 496,00 € |
Informazioni sul prodotto
Dasatinib is a tyrosine kinase inhibitor that inhibits the activity of several receptor tyrosine kinases, including c-Kit, PDGFRA, and PDGFRB. Dasatinib was developed for the treatment of acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), and other cancers. It is marketed in capsule form as a solution for oral administration. Dasatinib is insoluble in water but soluble in aqueous solutions with pH below 7.5. Dasatinib has been shown to be effective against liposome-encapsulated cancer cells, which may be due to its inhibition of extracellular liposomes.
Proprietà chimiche
Richiesta tecnica su: 3D-EJB00107 Dasatinib hydrochloride
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
